Mirae Asset Global ETFs Holdings’s Legend Biotech LEGN Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio LEGN Stock Details LEGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.6M	Buy	159,419 +70,855	+80%	+$1.91M	0.01%	893
2026 Q1	$1.6M	Buy	88,564 +3,583	+4%	+$68.3K	﹤0.01%	1277
2025 Q4	$1.85M	Buy	84,981 +24,803	+41%	+$710K	﹤0.01%	1183
2025 Q3	$1.96M	Sell	60,178 -1,458	-2%	-$53.8K	﹤0.01%	1156
2025 Q2	$2.19M	Sell	61,636 -10,566	-15%	-$342K	﹤0.01%	1052
2025 Q1	$2.45M	Sell	72,202 -4,593	-6%	-$165K	0.01%	1031
2024 Q4	$2.5M	Buy	76,795 +6,093	+9%	+$252K	0.01%	1017
2024 Q3	$3.45M	Sell	70,702 -15,636	-18%	-$833K	0.01%	885
2024 Q2	$3.82M	Buy	+86,338	New	+$3.98M	0.01%	831

Other funds holding LEGN

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's LEGN Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings increased its Legend Biotech (LEGN) stake by 80% in Q2 2026, buying an estimated $1.91M and bringing the position to 159,419 shares worth $4.6M. The position accounts for 0.01% of the portfolio, ranked #893.

Mirae Asset Global ETFs Holdings first reported a position in LEGN in Q2 2024 and has held it in 9 quarters since. 218 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.

Mirae Asset Global ETFs Holdings held 159,419 shares of Legend Biotech worth $4.6M as of Q2 2026.
Mirae Asset Global ETFs Holdings bought 70,855 Legend Biotech shares in Q2 2026, an estimated $1.91M.
Legend Biotech made up 0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #893 holding.
Mirae Asset Global ETFs Holdings first reported a position in Legend Biotech in Q2 2024 and has held it in 9 quarters since.
218 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.